ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Delaware » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Delaware

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWARD GOLDENBERG M.D.

Cardiovascular Disease

5,516

$793K

456
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 28%

$144
Average prescription price

Avg: $96

MICHAEL STILLABOWER M.D.

Cardiovascular Disease

5,196

$822K

465
427 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 28%

$158
Average prescription price

Avg: $96

RAJINDER PRASAD M.D.

Cardiovascular Disease

4,891

$553K

505
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$113
Average prescription price

Avg: $96

ANTHONY ALFIERI D.O.

Cardiovascular Disease

4,771

$564K

525
430 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$118
Average prescription price

Avg: $96

KENNETH SUNNERGREN M.D.

Cardiovascular Disease

4,686

$342K

576
535 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$73
Average prescription price

Avg: $96

FRANCIS PALERMO M.D.

Cardiovascular Disease

4,348

$339K

412
378 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $96

RAMON ROSA M.D.

Cardiovascular Disease

4,278

$396K

522
476 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$93
Average prescription price

Avg: $96

GEORGES DAHR MD

Cardiovascular Disease

3,873

$259K

490
405 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $96

GILBERT LEIDIG M.D.

Cardiovascular Disease

3,662

$304K

549
490 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$83
Average prescription price

Avg: $96

HABIB BOLOURCHI MD

Cardiovascular Disease

3,482

$275K

291
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$79
Average prescription price

Avg: $96

ARTHUR COLBOURN M.D.

Cardiovascular Disease

3,481

$351K

390
373 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$101
Average prescription price

Avg: $96

GURMEET SINGH M.D.

Cardiovascular Disease

3,370

$369K

427
317 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$110
Average prescription price

Avg: $96

ANTHONY FUREY D.O.

Cardiovascular Disease

3,260

$335K

401
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$103
Average prescription price

Avg: $96

ANDREW DOOREY M.D.

Cardiovascular Disease

3,248

$401K

343
307 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 28%

$124
Average prescription price

Avg: $96

PEDRO PEREZ M.D.

Cardiovascular Disease

3,116

$274K

398
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$88
Average prescription price

Avg: $96

JUDITH RIPPERT D.O.

Cardiovascular Disease

3,113

$326K

325
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$105
Average prescription price

Avg: $96

HENRY WEINER M.D.

Cardiovascular Disease

3,112

$323K

340
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$104
Average prescription price

Avg: $96

JOHN KELLY M.D.

Cardiovascular Disease

2,956

$230K

433
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $96

JAMES HOPKINS M.D.

Cardiovascular Disease

2,948

$227K

410
370 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$77
Average prescription price

Avg: $96

EHTASHAM QURESHI M.D.

Cardiovascular Disease

2,884

$266K

360
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$92
Average prescription price

Avg: $96

RONALD LEWIS M.D.

Cardiovascular Disease

2,872

$294K

360
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$103
Average prescription price

Avg: $96

DAVID RAMOS M.D.

Cardiovascular Disease

2,856

$272K

272
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$95
Average prescription price

Avg: $96

RAYMOND MILLER M.D.

Cardiovascular Disease

2,798

$297K

349
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$106
Average prescription price

Avg: $96

ERANGA HATHTHOTUWA MD

Cardiovascular Disease

2,706

$199K

284
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$74
Average prescription price

Avg: $96

HARJINDER GREWAL M.D.

Cardiovascular Disease

2,671

$277K

342
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$104
Average prescription price

Avg: $96

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank